Literature DB >> 32105672

Retinoids in health and disease: A role for hepatic stellate cells in affecting retinoid levels.

Maya W Haaker1, Arie B Vaandrager1, J Bernd Helms2.   

Abstract

Vitamin A (retinol) is important for normal growth, vision and reproduction. It has a role in the immune response and the development of metabolic syndrome. Most of the retinol present in the body is stored as retinyl esters within lipid droplets in hepatic stellate cells (HSCs). In case of liver damage, HSCs release large amounts of stored retinol, which is partially converted to retinoic acid (RA). This surge of RA can mediate the immune response and enhance the regeneration of the liver. If the damage persists activated HSCs change into myofibroblast-like cells producing extracellular matrix, which increases the chance of tumorigenesis to occur. RA has been shown to decrease proliferation and metastasis of hepatocellular carcinoma. The levels of RA and RA signaling are influenced by the possibility to esterify retinol towards retinyl esters. This suggests a complex regulation between different retinoids, with an important regulatory role for HSCs.
Copyright © 2020. Published by Elsevier B.V.

Entities:  

Keywords:  Hepatic stellate cells; Hepatocellular carcinoma; Hepatocyte; Liver; Retinoic acid; Retinol; Retinol binding protein

Year:  2020        PMID: 32105672     DOI: 10.1016/j.bbalip.2020.158674

Source DB:  PubMed          Journal:  Biochim Biophys Acta Mol Cell Biol Lipids        ISSN: 1388-1981            Impact factor:   4.698


  14 in total

Review 1.  Targeting fatty acid metabolism for fibrotic disorders.

Authors:  Seonghwan Hwang; Ki Wung Chung
Journal:  Arch Pharm Res       Date:  2021-10-18       Impact factor: 4.946

2.  Alleviation of liver cirrhosis and associated portal-hypertension by Astragalus species in relation to their UPLC-MS/MS metabolic profiles: a mechanistic study.

Authors:  Reham S Ibrahim; Nesrine S El-Mezayen; Alaa A El-Banna
Journal:  Sci Rep       Date:  2022-07-13       Impact factor: 4.996

Review 3.  Hepatic stellate cells in physiology and pathology.

Authors:  Dakota R Kamm; Kyle S McCommis
Journal:  J Physiol       Date:  2022-03-30       Impact factor: 6.228

4.  PNPLA3 rs738409 and risk of fibrosis in NAFLD: Exploring mediation pathways through intermediate histological features.

Authors:  Eduardo Vilar-Gomez; Carlos J Pirola; Silvia Sookoian; Laura A Wilson; Tiebing Liang; Naga Chalasani
Journal:  Hepatology       Date:  2022-04-21       Impact factor: 17.298

5.  Endothelin-1 in portal hypertension: The intricate role of hepatic stellate cells.

Authors:  Devaraj Ezhilarasan
Journal:  Exp Biol Med (Maywood)       Date:  2020-08-13

6.  Proteomic Changes of Activated Hepatic Stellate Cells.

Authors:  Maximilian Schinagl; Tamara Tomin; Juergen Gindlhuber; Sophie Honeder; Raphael Pfleger; Matthias Schittmayer; Michael Trauner; Ruth Birner-Gruenberger
Journal:  Int J Mol Sci       Date:  2021-11-26       Impact factor: 6.208

7.  Optimized protocol for the identification of lipid droplet proteomes using proximity labeling proteomics in cultured human cells.

Authors:  Clark W H Peterson; Kirandeep K Deol; Milton To; James A Olzmann
Journal:  STAR Protoc       Date:  2021-06-05

Review 8.  Nutrigenomics and Nutrigenetics in Metabolic- (Dysfunction) Associated Fatty Liver Disease: Novel Insights and Future Perspectives.

Authors:  Marcello Dallio; Mario Romeo; Antonietta Gerarda Gravina; Mario Masarone; Tiziana Larussa; Ludovico Abenavoli; Marcello Persico; Carmelina Loguercio; Alessandro Federico
Journal:  Nutrients       Date:  2021-05-15       Impact factor: 5.717

9.  Vitamin A in Nonalcoholic Fatty Liver Disease: A Key Player in an Offside Position?

Authors:  Carmen Berasain; Matias A Avila
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2020-09-21

10.  The Protection Conferred by HSD17B13 rs72613567 Polymorphism on Risk of Steatohepatitis and Fibrosis May Be Limited to Selected Subgroups of Patients With NAFLD.

Authors:  Eduardo Vilar-Gomez; Carlos J Pirola; Silvia Sookoian; Laura A Wilson; Tiebing Liang; Naga Chalasani
Journal:  Clin Transl Gastroenterol       Date:  2021-09-10       Impact factor: 4.488

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.